Illumina (ILMN) announced changes to its Board of Directors. Frances Arnold, PhD, Robert Epstein, MD, and Gary Guthart, PhD, will retire from the Board in connection with the company’s upcoming annual meeting of shareholders, and the Board has nominated David King to be elected as a member of the Board. King is the former Executive Chairman and CEO of Laboratory Corporation of America Holdings, and currently serves as a director and chair of both Privia Health and AmSurg Corporation, and as a director of Smith & Nephew.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina: Neutral Stance Amid Emerging Roche Competition and Incremental NovaSeq X Enhancements
- Labcorp, Illumina expand collaboration to broaden access to oncology testing
- Illumina announces strategic collaboration with Veritas Genetics
- Illumina, Southern Co, Corning, Seagate, Microchip Insider Shifts
- Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating